Sutro Biopharma (STRO) Capital Expenditures (2017 - 2025)
Sutro Biopharma (STRO) recorded Capital Expenditures of $184,000 in Q4 2025, down 82.8% from $1.07 million a year earlier and down 26.7% from the prior quarter.
Sutro Biopharma (STRO) Capital Expenditures (2017 - 2025) Analysis & Trends
For FY2025, Sutro Biopharma reported Capital Expenditures of $1.7 million, down 45.3% from FY2024.
- Annual Capital Expenditures has declined for four straight years, with a five-year compound annual growth rate of -25.0% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $3.1 million in FY2024 (-28.2%), $4.32 million in FY2023 (-45.1%), $7.86 million in FY2022 (-48.7%) and $15.32 million in FY2021 (+114.9%).
- Quarterly Capital Expenditures has ranged from $86,000 in Q2 2025 to $5.41 million in Q2 2021 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with an average decline of 7.1% over the last eight quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 211.4% in Q1 2021, against a decline of 88.6% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $251,000 (Q3 2025), $86,000 (Q2 2025) and $1.17 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Sutro Biopharma | 190.66 Mn | -487.84 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 184,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 446,000.00 |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 328,000.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 942,000.00 |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 738,000.00 |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 2.54 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 5.41 Mn |
| Mar 31, 2021 | 2.38 Mn |
Sutro Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=STRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();